These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32014162)

  • 21. Very early mobilization in stroke patients treated with intravenous recombinant tissue plasminogen activator.
    Arnold SM; Dinkins M; Mooney LH; Freeman WD; Rawal B; Heckman MG; Davis OA
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1168-73. PubMed ID: 25869770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolytic therapy in patients with acute ischemic stroke.
    Hinchey JA; Benesch C
    Arch Neurol; 2000 Oct; 57(10):1430-6. PubMed ID: 11030794
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombolysis for acute ischemic stroke--our experiences as part of SITS-MOST.
    Roje-Bedeković M; Vargek-Solter V; Corić L; Sabolek K; Breitenfeld T; Supanc V; Demarin V
    Acta Clin Croat; 2009 Sep; 48(3):287-93. PubMed ID: 20055250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Unblocking arteries to save brains: thrombolysis in patients with stroke].
    Merino JG; Hachinski V
    Med Clin (Barc); 2003 Jan; 120(1):17-8. PubMed ID: 12525300
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of Intravenous Thrombolysis for Acute Stroke in Patients with an Active Malignancy: Case Series and Review of the Literature.
    Alberte-Woodward M; da Silva-França CF; Rodríguez-Gay I; Pego-Reigosa R
    Eur Neurol; 2019; 81(3-4):163-166. PubMed ID: 31288236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
    Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
    JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infarct growth with and without intravenous thrombolysis in acute ischemic stroke.
    Baizabal-Carvallo JF
    Ann Neurol; 2012 Mar; 71(3):433; author reply 433-4. PubMed ID: 22451210
    [No Abstract]   [Full Text] [Related]  

  • 29. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subarachnoid hemorrhage--a rare complication after intravenous thrombolysis in an ischemic stroke patient.
    Chou CL; Lin YJ; Po HL; Chang CK
    Am J Emerg Med; 2010 Oct; 28(8):984.e1-3. PubMed ID: 20825835
    [No Abstract]   [Full Text] [Related]  

  • 31. [Stroke and thrombolysis in a basic hospital. A possible duty].
    Camacho JA; Jurado B; Jiménez JM; Montijano AJ; de Molina A
    Med Intensiva; 2006; 30(5):238-9. PubMed ID: 16938200
    [No Abstract]   [Full Text] [Related]  

  • 32. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision for intravenous thrombolysis in a young patient with acute vertical gaze palsy.
    Papadopoulou A; Ahlhelm FJ; Lyrer P; Kuhle J
    Acta Neurol Belg; 2015 Sep; 115(3):445-7. PubMed ID: 25182748
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous thrombolytic therapy for acute ischemic stroke.
    Cohen JE; Leker RR
    N Engl J Med; 2011 Sep; 365(10):964-5; author reply 966-7. PubMed ID: 21899472
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
    Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
    Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis for acute ischemic stroke.
    Tomsick TA
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 2):S67-76. PubMed ID: 15106579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
    Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
    Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Countering "brain attacks".
    Harvey J
    Nurs Manage; 2004 Aug; 35(8):27-32; quiz 33. PubMed ID: 15348964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shorter Intensive Care Unit Stays? The Majority of Post-Intravenous tPA (Tissue-Type Plasminogen Activator) Symptomatic Hemorrhages Occur Within 12 Hours of Treatment.
    Chang A; Llinas EJ; Chen K; Llinas RH; Marsh EB
    Stroke; 2018 Jun; 49(6):1521-1524. PubMed ID: 29686025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.